MX2020002859A - Composicion para decapoda, que comprende acido 5-aminolevulinico. - Google Patents

Composicion para decapoda, que comprende acido 5-aminolevulinico.

Info

Publication number
MX2020002859A
MX2020002859A MX2020002859A MX2020002859A MX2020002859A MX 2020002859 A MX2020002859 A MX 2020002859A MX 2020002859 A MX2020002859 A MX 2020002859A MX 2020002859 A MX2020002859 A MX 2020002859A MX 2020002859 A MX2020002859 A MX 2020002859A
Authority
MX
Mexico
Prior art keywords
decapod
aminolevulinic acid
composition
orally administered
administered composition
Prior art date
Application number
MX2020002859A
Other languages
English (en)
Inventor
Asuka SUMI
Shin Taniguchi
Ikuo Hirono
Hidehiro Kondo
Ivane PEDROSA-GERASMIO
Kentaro Imaizumi
Original Assignee
Neopharma Japan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neopharma Japan Co Ltd filed Critical Neopharma Japan Co Ltd
Priority claimed from JP2018168668A external-priority patent/JP2019055943A/ja
Publication of MX2020002859A publication Critical patent/MX2020002859A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Insects & Arthropods (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)

Abstract

La presente invención se refiere a una composición para administración oral para Decapoda que comprende ácido 5-aminolevulínico (5-ALA), y un método que comprende alimentar ácido 5-aminolevulínico a Decapoda. La composición para administración oral para Decapoda puede ser usada para criar y cultivar Decapoda, y puede prevenir y tratar efectivamente el síndrome de mortalidad temprana/enfermedad de necrosis hepatopancreática aguda (EMS/AHPND) causada por Vibrio parahaemolyticus como una bacteria patogénica. El crecimiento de Decapoda puede ser promovido por administración de una cantidad predeterminada de la composición para administración oral para Decapoda.
MX2020002859A 2017-09-19 2018-09-10 Composicion para decapoda, que comprende acido 5-aminolevulinico. MX2020002859A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017179379 2017-09-19
PCT/JP2018/033494 WO2019059027A1 (ja) 2017-09-19 2018-09-10 ５－アミノレブリン酸を含むエビ目用組成物
JP2018168668A JP2019055943A (ja) 2017-09-19 2018-09-10 ５−アミノレブリン酸を含むエビ目用組成物

Publications (1)

Publication Number Publication Date
MX2020002859A true MX2020002859A (es) 2020-07-24

Family

ID=65810251

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020002859A MX2020002859A (es) 2017-09-19 2018-09-10 Composicion para decapoda, que comprende acido 5-aminolevulinico.

Country Status (3)

Country Link
JP (1) JP2023055828A (es)
MX (1) MX2020002859A (es)
WO (1) WO2019059027A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4349401A1 (en) 2019-02-13 2024-04-10 Alpheus Medical, Inc. Non-invasive sonodynamic therapy
TW202106293A (zh) * 2019-04-26 2021-02-16 日商日本紐翱醫藥股份有限公司 黃病毒（ｆｌａｖｉｖｉｒｕｓ）感染症治療劑
CN112075551A (zh) * 2020-09-28 2020-12-15 北京挑战农业科技有限公司 一种用于提高水产养殖动物成活率的添加剂及其应用
AU2022308954A1 (en) 2021-07-09 2024-01-25 Sumitomo Chemical Company, Limited Composition for rearing organism belonging to order decapoda and composition for preventing or treating infection in decapods
WO2023180282A1 (en) * 2022-03-24 2023-09-28 Evonik Operations Gmbh Co-precipitates of methionylmethionine with organic compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100365151B1 (ko) * 2000-05-08 2003-02-11 김형락 어류 병원성 세균과 바이러스의 감염 예방 및 치료를 위한δ-아미노레불린산의 신규한 용도
KR101468610B1 (ko) * 2013-02-26 2014-12-04 한남바이오 주식회사 갑각류 양식용 사료 조성물

Also Published As

Publication number Publication date
JP2023055828A (ja) 2023-04-18
WO2019059027A1 (ja) 2019-03-28

Similar Documents

Publication Publication Date Title
MX2020002859A (es) Composicion para decapoda, que comprende acido 5-aminolevulinico.
WO2019199861A3 (en) Hemp extract for treatment of pain in animals
GB2491775A (en) Pulsatile drug release
NZ595585A (en) Animal feed compositions and feeding methods
NO20083965L (no) Anvendelse av olivenekstrakt som et pronaeringsstoff i dyrefôr
MX2020005942A (es) Delgada pelicula oral con alta carga de agente activo.
PH12019502150A1 (en) Compounds and methods for the treatment of parasitic diseases
EP4353317A3 (en) Ret inhibitor for use in treating cancer having a ret alteration
MX2022015629A (es) Uso de vibegron para tratar vejiga sobreactiva.
RU2016119285A (ru) Кормовая добавка и способ ее применения в молочном животноводстве
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
NZ758609A (en) A solid feed combination composition for ruminant calves
MX2021013826A (es) Mezcla nutricional a base de mct para proporcionar beneficios para la salud en animales.
MX2009008888A (es) Metodos para acelerar el desarrollo muscular, disminuir los depositos de grasa y mejorar la eficiencia alimenticia en cerdos.
RU2005104894A (ru) Способ повышения мясной продуктивности молодняка свиней на откорме
MY191983A (en) Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolyl-glycyl-l-tyrosinate and methods for preparing the same
RU2011108858A (ru) Средство для повышения роста и сохранности молодняка
Anderson Aminolevulinic acid
RU2014107146A (ru) Способ профилактики канцерогенного действия диэтилнитрозамина у экспериментальных животных
Vargas First report of proximal myopathy: case report
AR107734A1 (es) Métodos de tratamiento de diarrea en animales no humanos, neonatales y jóvenes, pre-destete
RU2010102484A (ru) Способ применения маточного молочка для увеличения фертильности
RU2017124565A (ru) Способ повышения качества молока высокопродуктивных коров
RU2010122270A (ru) Способ профилактики кетоза у высокопродуктивных молочных коров
Courboulay et al. Effects of piglet age on some indicators assessing pain at tail docking, with or without analgesia